BENJAMIN J. ZESKIND - 22 Dec 2022 Form 4 Insider Report for Immuneering Corp (IMRX)

Role: PRESIDENT AND CEO, Director, 10%+ Owner
Signature: /s/ Michael D. Bookman, Attorney-in-Fact for Benjamin J. Zeskind
Issuer symbol: IMRX
Transactions as of: 22 Dec 2022
Net transactions value: +$7,525
Form type: 4
Filing time: 27 Dec 2022, 07:14:23 UTC
Previous filing: 14 Apr 2022
Next filing: 17 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMRX	Class A Common Stock	Options Exercise	$7,525	+2,500	+0.11%	$3.01	2,261,852	22 Dec 2022	Direct
holding	IMRX	Class A Common Stock						894,927	22 Dec 2022	See Foonote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMRX	Stock Option	Options Exercise	$0	-2,500	-1.2%	$0.000000	203,500	22 Dec 2022	Class A Common Stock	2,500	$3.01	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Held by the Benjamin J. Zeskind 2020 Family Trust, where Lisa Schwartz, Dr. Zeskind's spouse, serves as sole trustee.
F2	The option has fully vested and is currently exercisable.